心外膜脂肪组织体积作为类风湿关节炎亚临床冠状动脉粥样硬化的标志物
本研究纳入139例类风湿关节炎(RA)患者和139例年龄性别匹配的对照,用CT血管造影评估心外膜脂肪组织体积(EATV)与冠状动脉斑块。RA与对照组EATV均值相似,但仅在RA患者中EATV与斑块负荷、非钙化斑块及易损斑块相关。EATV或可作为RA亚临床动脉粥样硬化和心血管风险的生物标志物。
要点
- RA患者与对照的EATV均值相似,但RA患者中合并动脉粥样硬化者EATV更高。
- 仅在RA患者中,EATV与斑块段数、多支或阻塞性病变、非钙化及易损斑块相关。
- 在病程<10年、无心血管危险因素且非肥胖的RA患者中,EATV仍与斑块段数相关。
核心结论
- 尽管RA患者与对照的EATV相似,但EATV仅在RA患者中与更大的斑块负荷及含非钙化成分和易损特征的斑块相关。
- EAT在RA中可能更具致病性,并参与早期动脉粥样硬化,其作为亚临床动脉粥样硬化和心血管风险生物标志物的价值有待进一步研究。
研究设计与样本
- 研究纳入139例RA患者和139例年龄、性别匹配的非RA对照,采用计算机断层扫描血管造影评估EATV和冠状动脉斑块。
- 所有评估EATV对斑块影响的模型均校正了年龄、性别、高血压、糖尿病、血脂异常、吸烟状态、冠心病家族史和肥胖(体重指数≥30 kg/m²)。
主要发现
- RA患者与对照的平均±标准差对数转换EATV相似(RA 4.69±0.36,对照4.70±0.42)。
- RA患者中合并动脉粥样硬化者EATV高于未合并者(P=0.046)。
- 在RA患者中,EATV对数单位每增加1个标准差,与斑块段数相关(率比1.20,95%CI 1.01-1.41),对照组无此关联(交互作用P=0.089)。
- 在RA患者中,EATV对数单位每增加1个标准差,与多支或阻塞性病变(OR 1.63,95%CI 1.04-2.61)、非钙化斑块(OR 1.78,95%CI 1.17-2.70)和易损斑块(OR 1.77,95%CI 1.03-3.04)相关,对照组无此关联(各交互作用P≤0.048)。
- 在病程<10年、未发生任何心血管危险因素且非肥胖的RA患者中,EATV与斑块段数相关(交互作用P≤0.017)。
临床怎么用
- 在RA患者中,EATV升高可能提示更高的斑块负荷及非钙化、易损斑块风险,可考虑作为亚临床动脉粥样硬化的影像标志物进行进一步评估。
- 对于病程较短、无传统心血管危险因素且非肥胖的RA患者,EATV与斑块段数的关联提示其或有助于早期风险识别。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess epicardial adipose tissue volume (EATV) and its link to coronary atherosclerosis and plaque morphology in patients with rheumatoid arthritis (RA) and in age- and sex-matched controls. METHODS: Computed tomography angiography was used to evaluate EATV and coronary plaque in 139 RA patients and 139 non-RA controls. All models assessing the effect of EATV on plaque were adjusted for age, sex, hypertension, diabetes, dyslipidemia, smoking status, family history of coronary artery disease, and obesity (body mass index of ≥30 kg/m2 ). Odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated. RESULTS: Mean ± SD log-transformed EATV was similar in patients with RA (4.69 ± 0.36) and controls (4.70 ± 0.42). EATV was higher in RA patients with atherosclerosis compared to those without atherosclerosis (P = 0.046). In stratified analyses, EATV was associated with the number of segments with plaque in RA patients (rate ratio 1.20 [95% CI 1.01-1.41] per 1-SD increment of log-unit increase in EATV) but not in controls (P for interaction = 0.089). Likewise, EATV (per 1-SD log-unit increase) was related to the presence of multivessel or obstructive disease (OR 1.63 [95% CI 1.04-2.61]), noncalcified plaque (OR 1.78 [95% CI 1.17-2.70]), and vulnerable plaque (OR 1.77 [95% CI 1.03-3.04]) in RA patients but not in controls (P for interaction ≤ 0.048 for each). Among RA patients, EATV was associated with the number of segments with plaque in those with RA for <10 years who did not develop any cardiovascular risk factors and who were not obese (P for interaction ≤ 0.017). CONCLUSION: Despite similar EATVs in RA patients and controls, EATVs were associated with greater plaque burden and presence of plaques with a noncalcified component and vulnerability features only in RA patients. EAT may be more pathogenic in RA and play a role in early-stage atherosclerosis. Its value as a biomarker of subclinical atherosclerosis and cardiovascular risk in RA warrants further studies.
引用
- Karpouzas GA, Rezaeian P, Ormseth SR, et al. Epicardial Adipose Tissue Volume As a Marker of Subclinical Coronary Atherosclerosis in Rheumatoid Arthritis. Arthritis Rheumatol. 2021. PMID: 33586363. doi:10.1002/art.41693
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。